Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed injection sites for Wegovy are the abdomen, the front of the thigh, and the upper arm — each equally valid, each giving reliable absorption when used correctly. Most people start with the abdomen, and that is sensible, but choosing your spot is only half the story. Where you inject matters far less than rotating within that site, which is the detail that often gets missed. Wegovy (semaglutide) is a prescription-only medicine for weight management, and a prescriber or the Patient Information Leaflet that comes with your pen is always your best reference for technique advice specific to you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear regularly is whether the abdomen is somehow superior, giving faster results or better absorption than the thigh or arm. It is not. The Wegovy prescribing information lists all three sites as suitable, and clinical practice does not single out one as therapeutically better. The abdomen became the go-to partly because it tends to have the most accessible subcutaneous fat for most people, making it easier to achieve the correct pinch of tissue. That practical ease is real, but it does not translate into a pharmacological advantage over a well-executed injection into the thigh or upper arm.
Where the confusion does matter is technique. A subcutaneous injection that accidentally goes intramuscular (too deep, wrong angle, insufficient pinch) can be more uncomfortable and may affect absorption. The solution is not to hunt for a magic site; it is to learn the technique properly for whichever site you use. The full guide to injecting with your Wegovy pen walks through the technique step by step, from preparing the pen to what to do after the click.
If needles make you nervous, you are far from alone. Many people starting weekly injections have never self-administered anything. A little uncertainty at the beginning is completely normal, and it usually passes within the first two or three doses once the routine clicks into place.
Each site has a usable zone, and staying within it reduces discomfort and protects tissue over the long term.
For the abdomen, the zone runs roughly two finger-widths away from the navel, covering the soft area to either side and below. Avoid the waistband area and any skin that is tender, bruised, scarred or hardened. For the front of the thigh, the middle third of the thigh is the target, avoid the inner thigh and the area around the knee. For the outer upper arm, the fleshy middle portion of the upper arm is used; this site can be harder to self-administer without a mirror, so many people use it only when someone else is injecting for them. You can read more about comparing these zones in the overview of all injection spots for Wegovy.
The NHS's patient guidance on semaglutide confirms these three sites and emphasises keeping injections subcutaneous, into the fatty tissue just below the skin, not into muscle. The NHS semaglutide medicines page is a straightforward reference if you want to cross-check anything you have read elsewhere.
Injecting into exactly the same patch of skin week after week causes lipohypertrophy, a hardening and thickening of fatty tissue that reduces absorption and can make injections less comfortable over time. This is the same principle that applies to any regularly injected medicine. It is avoidable with a simple habit: each week, move at least 1–2 cm from where you injected last time.
Many people find it easiest to work methodically around a site (left side of the abdomen one week, right side the next, for example) rather than trying to remember a specific spot. Some keep a brief note in their phone. Whatever system works for you is fine, provided you are genuinely moving the site each week rather than approximating. If you have been on treatment for a while and want to review your rotation approach, the best spot to inject Wegovy page covers long-term rotation habits in more detail, and advice for using your Wegovy pen beyond the first month addresses what changes as treatment continues.
One practical accessory worth having: cleaning the chosen site beforehand with an alcohol swab reduces infection risk. Our pharmacy stocks alcohol swabs if you need them alongside your treatment.
Choosing your injection site and choosing the right time of week to inject are separate decisions, but they interact. If you settle on a consistent day (say, every Saturday morning) your rotation becomes easier to track. The guide to the best time for your Wegovy injection explains how to pick a day that fits your routine and what to do if you miss your window.
Storage affects the injection experience more than many people expect. Wegovy is stored in the fridge between 2°C and 8°C, and a pen taken straight from the fridge can sting more on injection. Letting it reach room temperature for a few minutes before you use it is a small step that makes a noticeable difference for some people. How long you can keep a pen at room temperature and still use it safely is specified in the Patient Information Leaflet, refer to that rather than any general figure, because storage windows are product-specific.
If a site becomes noticeably hard, lumpy or persistently tender, stop using it and let it recover. Move to one of the other available sites and mention the change to your prescriber at your next review. Persistent skin changes at injection sites are worth flagging, they are not dangerous in themselves, but they can affect how reliably your dose is absorbed. Semaglutide's side effect profile is primarily gastrointestinal rather than site-related, but the NHS page on semaglutide lists what to watch for across the board.
If you are considering starting Wegovy or want a prescriber to review your current injection technique, speak to our prescribers, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.